Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Accured Expenses: 2019-2021

Historic Change in Accured Expenses for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to -$2.0 million.

  • Black Diamond Therapeutics' Change in Accured Expenses fell 156.92% to -$2.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $8.7 million, marking a year-over-year increase of 8.57%. This contributed to the annual value of -$756,000 for FY2024, which is 119.20% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Change in Accured Expenses of -$2.0 million as of Q4 2021, which was down 159.27% from $3.3 million recorded in Q3 2021.
  • Black Diamond Therapeutics' Change in Accured Expenses' 5-year high stood at $4.5 million during Q2 2021, with a 5-year trough of -$2.0 million in Q4 2021.
  • Its 3-year average for Change in Accured Expenses is $1.5 million, with a median of $1.8 million in 2020.
  • Per our database at Business Quant, Black Diamond Therapeutics' Change in Accured Expenses skyrocketed by 2,800.00% in 2020 and then slumped by 156.92% in 2021.
  • Black Diamond Therapeutics' Change in Accured Expenses (Quarterly) stood at $931,000 in 2019, then surged by 273.25% to $3.5 million in 2020, then slumped by 156.92% to -$2.0 million in 2021.
  • Its last three reported values are -$2.0 million in Q4 2021, $3.3 million for Q3 2021, and $4.5 million during Q2 2021.